Basit öğe kaydını göster

Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization

dc.contributor.authorNewell, Amy Hanlon
dc.contributor.authorMenzl, Ina
dc.contributor.authorPenault-Llorca, Frederique
dc.contributor.authorRossi, Giulio
dc.contributor.authorPate, Greg
dc.contributor.authorThunnissen, Erik
dc.contributor.authorHuang, Richard S. P.
dc.contributor.authorSmith, Derek
dc.contributor.authorLe, Catherine H.
dc.contributor.authorLiu, Wen-Wei
dc.contributor.authorManohar, Chitra
dc.contributor.authorOrdinario, Ellen
dc.contributor.authorLee, Michael
dc.contributor.authorRajamani, Jaya
dc.contributor.authorTruong, Huan
dc.contributor.authorLi, Jing
dc.contributor.authorChoi, Cindy
dc.contributor.authorLi, Jingchuan
dc.contributor.authorPati, Amrita
dc.contributor.authorBubendorf, Lukas
dc.contributor.authorBuettner, Reinhard
dc.contributor.authorKerr, Keith M.
dc.contributor.authorLopez-Rios, Fernando
dc.contributor.authorMarchetti, Antonio
dc.contributor.authorMarondel, Ivonne
dc.contributor.authorNicholson, Andrew G.
dc.contributor.authorOz, Aysim Buge
dc.contributor.authorPauwels, Patrick
dc.date.accessioned2021-03-02T18:14:46Z
dc.date.available2021-03-02T18:14:46Z
dc.date.issued2020
dc.identifier.citationHuang R. S. P. , Smith D., Le C. H. , Liu W., Ordinario E., Manohar C., Lee M., Rajamani J., Truong H., Li J., et al., "Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization", ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, cilt.144, sa.6, ss.735-741, 2020
dc.identifier.issn0003-9985
dc.identifier.othervv_1032021
dc.identifier.otherav_4716a83a-5f78-41ff-8131-3c4b4f357665
dc.identifier.urihttp://hdl.handle.net/20.500.12627/4763
dc.identifier.urihttps://doi.org/10.5858/arpa.2019-0085-oa
dc.description.abstractContext.-The ability to determine ROS1 status has become mandatory for patients with lung adenocarcinoma, as many global authorities have approved crizotinib for patients with ROS1-positive lung adenocarcinoma.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectDahili Tıp Bilimleri
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectPatoloji
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectTıp
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectBiyoloji ve Biyokimya
dc.subjectPATOLOJİ
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.titleCorrelation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization
dc.typeMakale
dc.relation.journalARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
dc.contributor.departmentVrije Universiteit Amsterdam , ,
dc.identifier.volume144
dc.identifier.issue6
dc.identifier.startpage735
dc.identifier.endpage741
dc.contributor.firstauthorID2283240


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster